Lv5
1228 积分 2022-11-19 加入
The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models
4天前
已完结
Unlocking the Potential of CDK4/6 Inhibitors: A Deep Dive into Abemaciclib, Palbociclib, and Ribociclib Succinate via DFT, Docking, Pharmacokinetics and MD Simulations
4天前
已完结
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
5天前
已完结
Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination
5天前
已完结
Engaging an engineered PARP-2 catalytic domain mutant to solve the complex structures harboring approved drugs for structure analyses
5天前
已完结
NLRP3 inflammasome mediates pyroptosis of alveolar macrophages to induce radiation lung injury
5天前
已完结
ACT001 Ameliorates ionizing radiation-induced lung injury by inhibiting NLRP3 inflammasome pathway
5天前
已完结
Low-dose radiation generated ROS-activatable doxorubicin prodrug loaded liposome nanoparticles for triple-negative breast cancer treatment
6天前
已完结
Investigating the therapeutic role of anlotinib in radiation-induced lung injury
7天前
已完结
Dihydroartemisinin Attenuates Radiation‐Induced Lung Injury by Inhibiting the cGAS/STING/NF‐κB Signaling Pathway
7天前
已完结
皖公网安备34019202002308
